Patent details
LUC00172
Product Name:
A combination of (a) 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and (b) N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide or a pharmaceutically acceptable salt thereof
Basic Information
- Publication number:
- LUC00172
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP161989223
- Legal Status:
- Inactive
- Application number:
- LUC00172
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1059
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 24/11/2015
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 11/08/2020
- First Marketing Authorization date:
- 24/11/2015
- Grant date:
- 14/12/2021
- Activation date:
- Publication date:
- 11/08/2020
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 24/11/2030
- SPC Extension Expiration:
- 24/11/2030
- Rejection date:
- Withdrawal date:
Owner
- From:
- 11/08/2020
-
-
- Name:
- Vertex Pharmaceuticals Incorporated
- Address:
- 50 Northern Avenue, Boston, MA 02210, United States (US)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 11/08/2020
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2020/10
- Publication date:
- 04/09/2020
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2022/01
- Publication date:
- 03/01/2022
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 01/01/2029
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-